Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
sibutraminhydrochloridmonohydrat 10 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
|
sibutraminhydrochloridmonohydrat 15 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
|
sibutraminhydrochloridmonohydrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
|
sibutraminhydrochlorid 5 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
|
Sibutramine hydrochloride 10mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
|
Sibutramine hydrochloride 15mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
|
sibutraminhydrochloridmonohydrat 10 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
|
sibutraminhydrochloridmonohydrat 15 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
|
sibutraminhydrochloridmonohydrat 10 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
1 |
sibutraminhydrochloridmonohydrat 10 mg kapsel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
1 |
sibutraminhydrochloridmonohydrat 15 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
1 |
sibutraminhydrochloridmonohydrat 15 mg kapsel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
1 |
sibutraminhydrochlorid 5 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
1 |
sibutraminhydrochlorid 5 mg kapsel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
1 |
sibutraminhydrochloridmonohydrat 10 mg kapsel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
1 |
sibutraminhydrochloridmonohydrat 15 mg kapsel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
1 |
sibutraminhydrochlorid 5 mg kapsel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sibutramine hydrochloride monohydrate (substance) |
Inferred relationship |
Some |
1 |